Belgium is committed to the development of advanced anti-cancer technologies and is a leader in the industry. iba develops, produces and supplies medical devices for proton radiotherapy, as well as software solutions for the diagnosis and treatment of cancer and for cancer diagnostics and patient quality control. In addition, the company has partnered with healthcare providers* to establish cancer clinical and academic medical centers that offer comprehensive and integrated patient-centered care. Today, IBA's oncology solutions are used in more than 3,000 hospitals worldwide.